Temple University Hospital was included in a Philadelphia Inquirer article on a legal settlement involving the 340B national drug discount program designed to strengthen the ability of qualifying nonprofit hospitals to serve low-income patients. Hospitals buy certain prescription medications at a discount and are then reimbursed for the full price from private insurers and Medicare. TUH is expected to receive $14.5 million in the legal settlement. Its 340B savings in fiscal year 2023 was $130 million. Michael A. Young, MHA, FACHE, President and CEO of Temple University Health System, was quoted in the Inquirer article.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH